Ohcanbohtosat - Allison Crosby‐Thompson

  • Čájehuvvo 1 - 4 / 4
Aiddostahte ozu
  1. 1
    Radiation for diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era: Analysis of the <scp>N</scp>ational <scp>C</scp>omprehensive <scp>C</scp>ancer <scp>N</scp>etwork lymphoma outcomes project

    Radiation for diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era: Analysis of the <scp>N</scp>ational <scp>C</scp>omprehensive <scp>C</scp>ancer <scp>N</scp>etwork lymph... Dahkki Bouthaina S. Dabaja, Ann Vanderplas, Allison Crosby‐Thompson, Gregory A. Abel, Myron S. Czuczman, Jonathan W. Friedberg, Leo I. Gordon, Mark Kaminski, Joyce C. Niland, Michael Millenson, Auayporn Nademanee, Andrew D. Zelenetz, Ann S. LaCasce, Maria Alma Rodriguez

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Transformed non‐Hodgkin lymphoma in the rituximab era: analysis of the <scp>NCCN</scp> outcomes database

    Transformed non‐Hodgkin lymphoma in the rituximab era: analysis of the <scp>NCCN</scp> outcomes database Dahkki Makiko Ban‐Hoefen, Ann Vanderplas, Allison Crosby‐Thompson, Gregory A. Abel, Myron S. Czuczman, Leo I. Gordon, Mark Kaminski, Jennifer L. Kelly, Michael Millenson, Auayporn Nademanee, Maria Alma Rodriguez, Andrew D. Zelenetz, Joyce C. Niland, Ann S. LaCasce, Jonathan W. Friedberg

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma

    KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma Dahkki Katherine N. Cahill, Howard R. Katz, Jing Cui, Juying Lai, Shamsah Kazani, Allison Crosby‐Thompson, Denise Garofalo, Mario Castro, Nizar N. Jarjour, Emily DiMango, Serpil C. Erzurum, Jennifer Trevor, Kartik Shenoy, Vernon M. Chinchilli, Michael E. Wechsler, Tanya M. Laidlaw, Joshua A. Boyce, Elliot Israel

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

    An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era Dahkki Zheng Zhou, Laurie H. Sehn, Alfred Rademaker, Leo I. Gordon, Ann S. LaCasce, Allison Crosby‐Thompson, Ann Vanderplas, Andrew D. Zelenetz, Gregory A. Abel, Maria Alma Rodriguez, Auayporn Nademanee, Mark Kaminski, Myron S. Czuczman, Michael Millenson, Joyce C. Niland, Randy D. Gascoyne, Joseph M. Connors, Jonathan W. Friedberg, Jane N. Winter

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: